Johnson & Johnson (JNJ)
Drug Manufacturers - General · Healthcare · $575.1B
Intrinsic Value (Consensus)
$227.13
Current Price
$235.18
Margin of Safety
-3.4%
3.4% Above Intrinsic Value
Value: $227
Price: $235
Valuation Model Estimates
Current Price: $235.18
DCF (Discounted Cash Flow)
$380.23
Graham Number
$91.07
Earnings Power Value
$107.09
Relative Value (P/E)
$220.60
Dividend Discount Model
$336.67
Consensus Value
$227.13
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
76
Profitability
25/25
Strength
23/25
Valuation
12/25
Growth
16/25
Financial Health Signals
Strong profitability — ROE of 33% (above 20% is excellent)
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $11.03
- EPS (Forward)
- $13.24
- Book Value
- $33.42
- P/E Ratio
- 21.7
- Forward P/E
- 18.1
- PEG Ratio
- —
- ROE
- 33.0%
- Debt/Equity
- 51%
- Revenue Growth
- 6.0%
- Earnings Growth
- 20.0%
- Dividend Yield
- 0.4%
- Beta
- 0.26
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance